share_log

公告精选 | 兖州煤业股份预计前三季净利同比增64.78%;维达国际前三季度总收益132亿港元

Selected Announcements | Yanzhou Coal Industry Co., Ltd. expects net profit for the first three quarters to increase 64.78% year-on-year; Vinda International's total revenue for the first three quarters was HK$13.2 billion

富途資訊 ·  Oct 22, 2021 08:30

Selection of blockbuster announcements

1、Yanzhou Coal Co., Ltd. (01171.HK) $It is estimated that the net profit of homing in the first three quarters will increase by 64.78% year on year to 11.5 billion yuan, and the sales of commercial coal in the third quarter will decrease by 33.15% year on year to 26.56 million tons.

Yanzhou Coal Co., Ltd. announced that according to the preliminary calculation of the company's financial department according to Chinese accounting standards, the company expects to achieve a net profit of about 11.5 billion yuan belonging to shareholders of listed companies in the first three quarters of 2021, compared with the data for the same period last year before retrospective adjustment. It will increase by 5.81 billion yuan, an increase of 102.09 percent over the same period last year. Compared with the retroactive adjusted data for the same period last year, it will increase by 4.521 billion yuan, an increase of 64.78% compared with the same period last year.

2、$Vinda International (03331.HK) $Total revenue of HK $13.2 billion in the first three quarters increased by 15.1% over the same period last year.

In the first three quarters of 2021, Vinda International's total income was 13.2 billion Hong Kong dollars, up 15.1% from a year earlier. Gross profit rose 11% to 4.83 billion yuan, while gross profit margin fell 1.4 percentage points to 36.6%. Operating profit narrowed by 13.1% to 1.565 billion yuan, while operating profit margin decreased by 3.8% to 11.9%.

3、$China Unicom (00762.HK) $The profit attributable to shareholders in the first three quarters increased 19.4% year on year to 12.923 billion yuan, a net increase of 7.884 million users of the 5G package in September.

In the first three quarters of 2021, China Unicom's income was 244.489 billion yuan, up 8.5% over the same period last year, and service income was 222.384 billion yuan, up 7.3% over the same period last year. EBITDA1 is 75.337 billion yuan, up 2.2% over the same period last year. The profit attributable to equity holders of the company was 12.923 billion yuan, up 19.4% from the same period last year.

4、$Sands China Ltd. (01928.HK) $Total net income in the third quarter was $611 million, up 265.87% from a year earlier.

Sands China Ltd. 's total net income in the third quarter of 2021 rose to $611 million from $167 million in the third quarter of 2020, up 265.87 per cent from a year earlier. Sands China posted a net loss of $423 million in the third quarter of 2021, compared with $562 million in the third quarter of 2020.

5、Red Star Macron (01528.HK) $The total amount of funds raised by the completion of the non-public offering of 449.7 million A shares is about 3.701 billion yuan.

Hongxing Metro announced that the company has completed a non-public offering of A shares. After the completion of the private offering of A shares, the total number of shares increased from 3.905 billion shares to about 4.355 billion shares, and the total number of A shares increased from about 3.164 billion A shares to 3.613 billion A shares. It is reported that the issue number of 449.7 million shares, the issue price of 8.23 yuan per share, the total amount of funds raised is about 3.701 billion yuan.

6、$Tianli Education (01773.HK) $Luo Shi, chairman of the board, is assisting the regulatory authorities in investigating the resumption of trading on October 22.

Tianli Education issued an announcement, according to recent news reports that Luo Shi, chairman of the board of directors, chief executive, executive director and controlling shareholder of the company, is being investigated by Chinese authorities. The board of directors was subsequently informed by Luo Shi's family that he was assisting the regulatory authorities in the investigation for personal reasons and that the company had not received any notice from any regulatory authorities on the investigation.

The remaining members of the board are not aware of any indication that the investigation is related to the company and its operations. The Board also confirmed that its decision-making process and the day-to-day operation of the company were normal.

The company has applied to the Stock Exchange to resume trading with effect from 09:00 on October 22nd, 2021.

  • Financial report data

Yanzhou Coal (01171) expects the return net profit in the first three quarters to increase by 64.78% year-on-year to 11.5 billion yuan. Commercial coal sales in the third quarter decreased by 33.15% to 26.56 million tons.

Total income of HK $13.2 billion in the first three quarters of Vinda International (03331) increased by 15.1% over the same period last year.

China Unicom (00762) the profit attributable to shareholders in the first three quarters increased by 19.4% year-on-year to 12.923 billion yuan, a net increase of 7.884 million users of the 5G package in September.

CSPC Pharmaceutical (01093): the third quarter net profit of 300765.SZ increased by 4.22% to 80.9787 million yuan.

Minmetals Resources (01208) Total Copper output in the third quarter 91200 tons Zinc output 61800 tons

China Lilang (01234) the retail sales of "LILANZ" products recorded medium to high unit growth in the third quarter of 2021 compared with the same period last year.

King International (00163) expects to turn from a loss to a profit of more than HK $150 million in the medium term

Sands China Ltd. (01928) third quarter net income totaled US $611 million, up 265.87% from the same period last year.

Trend in China (03818) the cumulative retail flow of the platform decreased year by year in the first half of the year.

The contract sales of Sanson Group (06611) accumulated 6.41 billion yuan in the first 9 months.

  • AH interaction

Hongxing Metro (01528) completed a non-public offering of 449.7 million A shares and raised a total of about 3.701 billion yuan.

  • Important matters

Hopson Development (00754) clarifies: categorically denies the allegations made against him expressly or implicitly in the announcement of the seller's guarantor

Sihuan Pharmaceutical (00460): application for listing of Annalprazole Sodium New Drug accepted

BeiGene, Ltd. (06160): Baiyueze ®(Zebutini) is approved in Russia for the treatment of patients with recurrent or refractory mantle cell lymphoma

Kangfang Bio-B (09926): TIGIT Monoclonal Antibody combined with Kaidenin in the treatment of Advanced or metastatic solid tumor completed the first case of Drug Administration

Zai Lab Limited-SB (09688): proof of concept of a new all-human VH antibody fragment ZL-1102 in phase 1b clinical study of psoriasis

Junshi Bio (01877): the clinical trial application of JS019 injection in the treatment of advanced malignant tumor was accepted.

Pioneering Pharmaceutical Industry-B (09939): the clinical trial of GT90008 in the treatment of advanced solid tumor has been approved by the China Drug Administration.

The Emperor Palace (00286) signed a strategic cooperation agreement with Ascot to speed up the establishment of the Crescent Center.

Longfor Group (00960) issued 1 million shares due to the exercise of the option.

  • Resume trading and suspend trading

Tianli Education (01773): board Chairman Luo Shi is assisting the regulatory authorities in investigating the resumption of trading on October 22nd.

Hengyi Holdings (01894) may delay the publication of results and continue to suspend trading.

  • Asset merger and acquisition

Shenzhen International (00152) plans to acquire a 70% stake in Shenzhen Saige Technology for no more than 333.5 million yuan.

Greentown Service (02869) plans to spend 22 million yuan to acquire a 20% stake in Hangzhou Jiancheng.

  • Repurchase cancellation

China Gas (00384) spent HK $67.848 million to buy back 3.4224 million shares on October 21.

Genting Xinyao-B (01952) spent about HK $18.4363 million to buy back 423500 shares on October 21.

Sino Biopharmaceutical (01177) invested 10.1028 million Hong Kong dollars to buy back 1.7 million shares on October 21.

Stone four Pharmaceutical Group (02005) spent HK $9.91 million to buy back 2.5 million shares on October 21.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment